MIPCOVI
The "MIPCOVI" trademark, serial number 77675545 , was filed on 22nd of February 2009 with a mark drawing code of 4000 and its transaction date is 77675545. Since 25th of July 2012, the document can be found in the M10 law office in the publication and issue section. The employee responsible is VOHRA, SANJEEV KUMAR and the date it was published for opposition on 11/17/2009. The status of this trademark was checked last on 07/24/2012.
The "MIPCOVI" trademark, serial number 85819976 , was filed on 10th of January 2013 with a mark drawing code of 4000 and its transaction date is 85819976. The attorney assigned is Marc Stanislawczyk, attorney docket number BMS212/US. Since 20th of March 2014, the document can be found in the M10 law office in the publication and issue section. The employee responsible is VOHRA, SANJEEV KUMAR and the date it was published for opposition on 12/24/2013. The date when we last checked the status of this trademark was 02/18/2014.
The corresponded responsible for this trademark is Marc Stanislawczyk, located at AstraZeneca Pharmaceuticals LLP, FOP3-022, 1800 Concord Pike.The state or country where the trademark was organized is by Astrazeneca Ab. The legal entity type behing it is a Company, located at Vastra Malarehamnen 9, Sodertalje, zip SE-151 85 and also by Bristol-myers Squibb Company - Corporation, located at 345 Park Avenue, New York, NY zip 10154.Other trademarks by this applicant: ATACAND PLUS, ESOMEP, ORAL DTI.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 01/17/2013 |
Primary Code | 005 |
Goods codes | |
GS0051 | Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
03/19/2014 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | I - Incoming Correspondence | ASGN | |
03/18/2014 | ATTORNEY REVOKED AND/OR APPOINTED | I - Incoming Correspondence | ARAA - ATTORNEY REVOKED AND/OR APPOINTED | |
03/18/2014 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | I - Incoming Correspondence | REAP - TEAS REVOKE/APPOINT ATTORNEY RECEIVED | |
02/18/2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
12/24/2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
12/24/2013 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
12/04/2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
11/18/2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
11/18/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
10/29/2013 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
10/29/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
10/28/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
10/28/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
04/26/2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
04/26/2013 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
04/26/2013 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
04/24/2013 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
04/03/2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
01/17/2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
01/14/2013 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.